The influence of steroid type on outcomes in patients with acute respiratory distress syndrome.

Abstract

BACKGROUND:

Recent systematic reviews and meta-analyses have suggested that low-dose steroids are effective in the treatment of acute respiratory distress syndrome (ARDS). Recent guidelines recommend the use of low-dose steroids instead of high-dose steroids. These systematic reviews were conducted based on the concept that the effect of steroids is constant regardless of their type. We discuss whether the type of steroid used influences the outcomes in patients with ARDS.

MAIN BODY:

From a pharmacological standpoint, methylprednisolone has little activity as a mineralocorticoid and may cause pulmonary hypertension. The results of the rank probability of our previous network meta-analysis revealed that low-dose methylprednisolone might be an optimal treatment compared to using other types of steroids or no steroids in terms of ventilator-free days. Similarly, an analysis of individual data from four randomized controlled trials suggested that low-dose methylprednisolone was associated with decreased mortality in patients with ARDS. Dexamethasone has attracted the attention of clinicians as a novel adjunct therapy for ARDS.

CONCLUSION:

Recent evidence has shown that low-dose methylprednisolone may be an effective treatment option for ARDS. The timing of initiation and duration of low-dose methylprednisolone therapy should be verified in future studies.

• Authors: Shodai Yoshihro, Shunsuke Taito, Tomoaki Yatabe
• Journal: Journal of intensive care (J Intensive Care) Vol. 11 Issue 1 Pg. 32 (Jul 10 2023) ISSN: 2052-0492 [Print] England
• PMID: 37430366 (Publication Type: Letter)
• Copyright: © 2023. The Author(s).